Evidence map›Paper›PMID 31852798›Full record

ArticleScience translational medicine2019

Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8

Son Nguyen, Claire Deleage, Samuel Darko, Amy Ransier, Duc P Truong, Divyansh Agarwal, Alberto Sada Japp, Vincent H Wu, Leticia Kuri-Cervantes, Mohamed Abdel-Mohsen and 13 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 123 citations in OpenAlex.

  1. Epigenetic scars of CD8Nature immunology · 2021
    Trial
  2. Article
  3. Review
  4. A Versatile Anti-CXCR5 Monoclonal Antibody (CxCurrent issues in molecular biology · 2026
    Article
  5. Review
  6. Article
  7. HIV controllers, lessons learnt from the lymphoid tissues.Current opinion in HIV and AIDS · 2026
    Review
  8. Review
  9. Early immune responses anticipate HIV rebound and precede viral control.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Roadmap for spatial transcriptomics of HIV in tissues.Current opinion in HIV and AIDS · 2025
    Review
  13. Therapeutic CD8Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Article
  17. Review
  18. Application of mass cytometry in the immune microenvironment of breast cancer.Medical oncology (Northwood, London, England) · 2025
    Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 4 countries.

Son NguyenDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-0475-5158
Claire DeleageAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.ORCID 0000-0002-3507-0055
Samuel DarkoHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-9711-8122
Amy RansierHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Duc P TruongDepartment of Mathematics, Southern Methodist University, Dallas, TX 75205, USA.ORCID 0000-0002-9806-3274
Divyansh AgarwalDepartment of Statistics, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-0404-6877
Alberto Sada JappDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0001-8106-8987
Vincent H WuDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-8640-6065
Leticia Kuri-CervantesDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-2432-9500
Mohamed Abdel-MohsenThe Wistar Institute, Philadelphia, PA 19104, USA.ORCID 0000-0002-9945-4314
Perla M Del Rio EstradaDepartamento de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City 14080, Mexico.ORCID 0000-0003-3366-3268
Yuria Ablanedo-TerrazasDepartamento de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City 14080, Mexico.
Emma GostickDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.ORCID 0000-0002-3628-5824
James A HoxieDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-6257-4902
Nancy R ZhangDepartment of Statistics, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-0880-5749
Ali NajiDepartment of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-6926-3306
Gustavo Reyes-TeránDepartamento de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City 14080, Mexico.ORCID 0000-0001-7295-8240
Jacob D EstesVaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR 97239, USA.ORCID 0000-0002-9652-6394
David A PriceDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.ORCID 0000-0001-9416-2737
Daniel C DouekHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Steven G DeeksDepartment of Medicine, University of California, San Francisco General Hospital, San Francisco, CA 94110, USA.ORCID 0000-0001-6371-747X
Marcus BuggertDepartment of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.ORCID 0000-0003-0633-1719
Michael R BettsDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. betts@pennmedicine.upenn.edu.ORCID 0000-0002-7690-1484
University of Pennsylvania · USInstituto Nacional de Enfermedades Respiratorias · MXNational Institutes of Health · USCardiff University · GBKarolinska University Hospital · SELeidos (United States) · USOregon National Primate Research Center · USSan Francisco General Hospital · USSouthern Methodist University · USThe Wistar Institute · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
First-in-human study of two anti-SARS CoV-2 antibodies in health volunteersUM1AI126620 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J, RILEY, JAMES L. · 2016 to 2021
$24.5M
T cell functionality and control of HIV infectionR01AI076066 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R · 2008 to 2017
$4.6M
Role of Intestinal Barrier Integrity in Modulating the Host Glycome During COVID-19R01DK123733 · NIDDK · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, KESHAVARZIAN, ALI · 2020 to 2024
$4.5M
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph nodeR01AI118694 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R · 2015 to 2019
$3.3M
Sialic Acid Modulation of HIV-associated Chronic InflammagingR01AG062383 · NIA · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED · 2019 to 2023
$3.0M
Exploring Cell-free Glycomic Interactions in HIV-associated Neurological DisordersR21NS106970 · NINDS · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, NDHLOVU, LISHOMWA C · 2017 to 2018
$507k
Role of Host Glycosylation in the Galectin-9-Mediated Reversal of HIV LatencyR21AI129636 · NIAID · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED · 2017 to 2018
$496k
Host Glycomic Determinants of HIV Persistence in vivoR21AI143385 · NIAID · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED · 2019 to 2020
$491k
NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI076066NIAID NIH HHS R01 AI118694NIAID NIH HHS R21 AI129636NIAID NIH HHS R21 AI143385NIAID NIH HHS UM1 AI126620NIH HHS P51 OD011092Wellcome TrustWellcome Trust 100326/Z/12/Z
6 · The paper itself

Abstract

The functional properties of circulating CD8

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHIV-1HIV InfectionsHumansLymphoid TissueViral Load

Identifiers

PMID31852798
PMCPMC7265335
OpenAlexW2995311491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.